Memo Therapeutics
Switzerland - Schlieren
BiotechnologyFocus: Antibody Discovery Technology
Memo Therapeutics is a life sciences company focused on Antibody Discovery Technology.
Nephrology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
MTx-COVAB36
SARS-CoV-2 InfectionClinical Trials (1)
NCT05351437To Assess the Safety and Tolerability of MTx-COVAB36 as a Therapeutic and Prophylactic Treatment Against COVID-19.
Phase 1AntiBKV
BK Virus NephropathyClinical Trials (1)
NCT05358106Assess Safety, Tolerability and Pharmacokinetics of AntiBKV in Healthy Adult Volunteers.
Phase 1Anti-BK polyomavirus
BK Viremia; BKV DNAemiaClinical Trials (1)
NCT05769582Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients
Phase 2/3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2024
Portfolio: 3 clinical trials
Top TAs: Nephrology
Publications: 5 in PubMed